Target intelligence / Profile preview

Epidemic Vibrio cholerae surface receptors

Molecular classification
Receptor, Other
01

Overview

Epidemic Vibrio cholerae surface receptors refer to the key molecular structures on the outer membrane of Vibrio cholerae strains, specifically the O1 and O139 serogroups, that facilitate infection and colonization. The primary components include the O-antigen of the lipopolysaccharide (LPS) and the toxin-coregulated pilus (TCP). The O-antigen is the major surface antigen used for serotyping and is the principal target for protective immunity elicited by oral cholera vaccines. The TCP is a type IV pilus essential for bacterial aggregation and attachment to the host's small intestine, and it also serves as the receptor for the CTXphi bacteriophage, which introduces the cholera toxin genes. Therapeutic strategies, including vaccines and experimental monoclonal antibodies, target these receptors to prevent the bacterium from establishing a niche in the gut, thus preventing the production of cholera toxin and the resulting severe diarrheal disease.

Other names
Vibrio cholerae O-antigenToxin-coregulated pilus (TCP)Vibrio cholerae surface antigensO1 antigenO139 antigenVibrio cholerae lipopolysaccharide
02

Mechanism of action

Vaccines and antibodies bind to these surface receptors to inhibit bacterial adherence to the intestinal mucosa and prevent colonization, thereby blocking the infection process.

03

Biological functions

AdhesionCell colonizationPathogenesisImmune responseBacteriophage receptor binding
04

Disease associations

Infection
05

Safety considerations

Serogroup switching (e.g., O1 to O139)Vaccine-induced gastrointestinal side effectsLimited cross-protection between different serogroups
06

Interacting drugs

Oral cholera vaccine

4 more in the full profile.

07

Biomarkers

Vibrio cholerae O1 serotypeVibrio cholerae O139 serotypeAnti-LPS antibody titerAnti-TCP antibody titerVibriocidal antibody titer

Beyond the preview

Go deeper on Epidemic Vibrio cholerae surface receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epidemic Vibrio cholerae surface receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call